A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Aspirin adherence during high-risk pregnancies, a questionnaire study. | LitMetric

Aspirin adherence during high-risk pregnancies, a questionnaire study.

Pregnancy Hypertens

Department of Obstetrics and Gynecology, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. Electronic address:

Published: October 2016

AI Article Synopsis

  • Aspirin is known to lower the risk of recurrent hypertensive disorders and fetal growth restrictions in high-risk pregnancies, prompting a study on adherence rates.
  • The study surveyed women between 24 and 36 weeks gestation using validated questionnaires, revealing non-adherence rates of 46.3% and 21.4% based on different measures.
  • No significant differences in demographics or pregnancy backgrounds were found between women who adhered to aspirin and those who did not, indicating that adherence cannot be assumed in this group.

Article Abstract

Objective: Aspirin reduces the risk of recurrent hypertensive disorders of pregnancy (HD) and fetal growth restriction (FGR). This study examined the non-adherence rates of aspirin in women with high-risk pregnancies.

Study Design: All consecutive women between 24 and 36weeks gestation with an indication for aspirin use during pregnancy were invited for this study. A survey was used which included two validated questionnaires, the simplified medication adherence questionnaire (SMAQ) and the Beliefs and Behaviour Questionnaire (BBQ).

Main Outcome Measures: To determine the non-adherence rates of aspirin, and to identify the beliefs and behavior concerning aspirin.

Results: Indications for aspirin use during pregnancy were previous HD, FGR, intrauterine fetal death or current maternal disease. Non-adherence rates according to the SMAQ and BBQ were 46.3% and 21.4% respectively. No differences in demographic background or obstetrical characteristics between adherent and non-adherent women could be demonstrated.

Conclusions: Adherence for aspirin in this high-risk population cannot be taken for granted. The non-adherence rates in pregnant women are comparable with the non-adherence rates for aspirin in the non-pregnant population.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.preghy.2016.08.232DOI Listing

Publication Analysis

Top Keywords

non-adherence rates
20
rates aspirin
12
aspirin
8
aspirin pregnancy
8
non-adherence
5
rates
5
aspirin adherence
4
adherence high-risk
4
high-risk pregnancies
4
pregnancies questionnaire
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!